Hypoxia Inducible Factor (HIF) Inhibitors
| Cat. No. | 产品名称/活性 |
|---|---|
| 5953 | Adaptaquin |
| HIF-prolyl hydroxylase-2 (PHD2) inhibitor; antioxidant | |
| 4408 | DMOG |
| Inhibitor of hypoxia-inducible factor α (HIF-α) prolyl hydroxylase (HIF-PH) | |
| 5520 | Echinomycin |
| Highly potent and selective HIF-1α inhibitor | |
| 6653 | FM19G11 |
| HIF α-subunit inhibitor | |
| 5655 | GN 44028 |
| Potent HIF-1α inhibitor | |
| 4451 | IOX 2 |
| Potent, selective HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor | |
| 4324 | KC7F2 |
| HIF-1α inhibitor; down-regulates HIF-1α protein synthesis | |
| 6322 | LW 6 |
| HIF-1α inhibitor; inhibits cellular accumulation of HIF-1α; also malate dehydrogenase-2 inhibitor | |
| 2954 | PX 12 |
| Thioredoxin-1 inhibitor; attenuates expression of HIF-1α | |
| 5243 | TC-S 7009 |
| High affinity and selective HIF-2α inhibitor | |
| 7774 | VH 032 |
| Inhibitor of VHL; blocks interaction of VHL and HIF-α | |
| 6156 | VH 298 |
| High-affinity inhibitor of VHL; blocks interaction of VHL and HIF-α |
Cancer Metabolism Product Guide
Our product guide reviews some of the main areas in cancer metabolism research and highlights products that can be used to explore metabolic pathways.
Request copyRequest PDFAngiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF